D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Chemistry D-index 64 Citations 12,871 401 World Ranking 3754 National Ranking 49
Biology and Biochemistry D-index 67 Citations 13,087 311 World Ranking 3578 National Ranking 63

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Organic chemistry
  • Gene

Stereochemistry, Structure–activity relationship, Virology, Virus and Chemical synthesis are his primary areas of study. The study incorporates disciplines such as Biological activity and Potency in addition to Stereochemistry. His Structure–activity relationship research is multidisciplinary, incorporating elements of IC50, Benzimidazole and Anti hiv activity.

His Virology research includes elements of Mutation, Efavirenz, Transactivation and Mechanism of action. His Virus research includes themes of Integrase and Molecular biology. His study in Chemical synthesis is interdisciplinary in nature, drawing from both Lactam, Reverse-transcriptase inhibitor, Thiadiazoles, Bicyclic molecule and Enzyme inhibitor.

His most cited work include:

  • Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later (262 citations)
  • Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. (231 citations)
  • Synthesis and antiviral activity of new pyrazole and thiazole derivatives (209 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Stereochemistry, Reverse transcriptase, Virology, Structure–activity relationship and In vitro. The concepts of his Stereochemistry study are interwoven with issues in Combinatorial chemistry and Chemical synthesis. His studies examine the connections between Chemical synthesis and genetics, as well as such issues in Reverse-transcriptase inhibitor, with regards to Enzyme inhibitor and Nucleotidyltransferase.

Christophe Pannecouque has included themes like Nevirapine, Mutant and Enzyme in his Reverse transcriptase study. His research links Integrase with Virology. His studies link Cell culture with Structure–activity relationship.

He most often published in these fields:

  • Stereochemistry (55.43%)
  • Reverse transcriptase (32.76%)
  • Virology (22.10%)

What were the highlights of his more recent work (between 2015-2021)?

  • Stereochemistry (55.43%)
  • Reverse transcriptase (32.76%)
  • Mutant (9.33%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Stereochemistry, Reverse transcriptase, Mutant, Etravirine and Combinatorial chemistry. His study in Stereochemistry focuses on Molecular model in particular. His Reverse transcriptase research is multidisciplinary, relying on both Structure–activity relationship, Pyrimidine and Enzyme.

His Enzyme study incorporates themes from In vitro, Viral replication and Virology. In his research on the topic of Mutant, Drug resistance is strongly related with Mutation. His work carried out in the field of Etravirine brings together such families of science as Rilpivirine, Bioavailability, Efavirenz, Nevirapine and Drug discovery.

Between 2015 and 2021, his most popular works were:

  • Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends (157 citations)
  • Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles. (67 citations)
  • Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks (50 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Organic chemistry
  • Gene

His scientific interests lie mostly in Stereochemistry, Reverse transcriptase, Diarylpyrimidines, Combinatorial chemistry and Structure–activity relationship. His Stereochemistry research incorporates themes from Mutant and Cytotoxicity. Christophe Pannecouque combines subjects such as Potency and Pyrimidine with his study of Reverse transcriptase.

Christophe Pannecouque has researched Diarylpyrimidines in several fields, including Anti hiv and Efavirenz. His research integrates issues of Cancer cell, Molecular network and Combinatorial Chemistry Techniques in his study of Structure–activity relationship. His Nucleoside Reverse Transcriptase Inhibitor research integrates issues from Hiv treatment, Virus, Virology and Infectious agent.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later

Christophe Pannecouque;Dirk Daelemans;Erik De Clercq.
Nature Protocols (2008)

397 Citations

Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis.

Myriam Witvrouw;Christophe Pannecouque;William M Switzer;Thomas M Folks.
Antiviral Therapy (2004)

349 Citations

Synthesis and antiviral activity of new pyrazole and thiazole derivatives

Osama I. El-Sabbagh;Mohamed M. Baraka;Samy M. Ibrahim;Christophe Pannecouque.
European Journal of Medicinal Chemistry (2009)

336 Citations

Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agents

Maria Letizia Barreca;Alba Chimirri;Laura De Luca;Anna-Maria Monforte.
Bioorganic & Medicinal Chemistry Letters (2001)

306 Citations

Synthesis and antiviral activity evaluation of some new 6-substituted 3-(1-adamantyl)-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles.

Marina Kritsanida;Anastasia Mouroutsou;Panagiotis Marakos;Nicole Pouli.
Farmaco (2002)

274 Citations

Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents.

Maria L. Barreca;Jan Balzarini;Alba Chimirri;Erik De Clercq.
Journal of Medicinal Chemistry (2002)

240 Citations

Anti-HIV Drug Discovery and Development: Current Innovations and Future Trends

Peng Zhan;Christophe Pannecouque;Erik De Clercq;Xinyong Liu.
Journal of Medicinal Chemistry (2016)

238 Citations

Design, synthesis, and evaluation of 2-aryl-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.

Ravindra K. Rawal;Rajkamal Tripathi;S.B. Katti;Christophe Pannecouque.
Bioorganic & Medicinal Chemistry (2007)

216 Citations

Polyanionic (i.e., polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in the virus replicative cycle.

Myriam Witvrouw;Valery Fikkert;Wim Pluymers;Barry Matthews.
Molecular Pharmacology (2000)

203 Citations

Plant lectins are potent inhibitors of coronaviruses by interfering with two targets in the viral replication cycle.

Els Keyaerts;Leen Vijgen;Christophe Pannecouque;Els Van Damme.
Antiviral Research (2007)

194 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Christophe Pannecouque

Erik De Clercq

Erik De Clercq

Rega Institute for Medical Research

Publications: 97

Jan Balzarini

Jan Balzarini

Rega Institute for Medical Research

Publications: 80

Dominique Schols

Dominique Schols

Rega Institute for Medical Research

Publications: 53

Robert Snoeck

Robert Snoeck

KU Leuven

Publications: 46

Graciela Andrei

Graciela Andrei

KU Leuven

Publications: 46

Erik De Clercq

Erik De Clercq

KU Leuven

Publications: 40

Lieve Naesens

Lieve Naesens

Rega Institute for Medical Research

Publications: 40

Johan Neyts

Johan Neyts

Rega Institute for Medical Research

Publications: 38

Piet Herdewijn

Piet Herdewijn

Rega Institute for Medical Research

Publications: 38

Anne-Mieke Vandamme

Anne-Mieke Vandamme

Rega Institute for Medical Research

Publications: 36

Yong-Tang Zheng

Yong-Tang Zheng

Kunming Institute of Zoology

Publications: 32

Mark A. Wainberg

Mark A. Wainberg

McGill University

Publications: 30

José A. Esté

José A. Esté

Autonomous University of Barcelona

Publications: 28

Zeger Debyser

Zeger Debyser

KU Leuven

Publications: 27

Kristel Van Laethem

Kristel Van Laethem

Rega Institute for Medical Research

Publications: 26

Chang-Yih Duh

Chang-Yih Duh

National Sun Yat-sen University

Publications: 24

Trending Scientists

Martin J. Strauss

Martin J. Strauss

University of Michigan–Ann Arbor

Jun-ichi Anzai

Jun-ichi Anzai

Tohoku University

Gudmund Skjåk-Bræk

Gudmund Skjåk-Bræk

Norwegian University of Science and Technology

Charles E. Kolb

Charles E. Kolb

Aerodyne Research

Mei-Xiang Wang

Mei-Xiang Wang

Tsinghua University

Peter Trontelj

Peter Trontelj

University of Ljubljana

José Iriarte

José Iriarte

University of Exeter

Nicole King

Nicole King

University of California, Berkeley

Narinder K. Mehra

Narinder K. Mehra

All India Institute of Medical Sciences

Shuh-Ji Kao

Shuh-Ji Kao

Xiamen University

Brian H. Luckman

Brian H. Luckman

University of Western Ontario

Philip M. Podsakoff

Philip M. Podsakoff

University of Florida

Kiara R. Timpano

Kiara R. Timpano

University of Miami

Jian'an Luan

Jian'an Luan

University of Cambridge

Kenneth Ouriel

Kenneth Ouriel

Cleveland Clinic

Russell J. Skiba

Russell J. Skiba

Indiana University

Something went wrong. Please try again later.